Rénibus Therapeutics
Norma Schafer has over 20 years of experience in Regulatory Affairs. Norma began their career in 1998 as the Director and Regulatory Affairs at Alcon Laboratories, Inc. In 2014, they moved to ZS Pharma to take on the role of Regulatory Affairs. In 2017, they became the Vice President of Regulatory Affairs and Quality Assurance at Urgo Medical North America, formerly SteadMed Medical. In 2021, they began their current role as Vice President Regulatory Affairs at Rénibus Therapeutics Inc. Additionally, they have experience as a Regulatory Affairs Instructor at San Diego State University, which they began in 2009.
Norma Schafer earned their Masters in Regulatory Affairs from San Diego State University between 2002 and 2005. Norma also obtained a Bachelor of Science (BS) in Medical Technology from Baylor University Medical Center. Additionally, in December 2001, they obtained a RAC-US certification from the Regulatory Affairs Certification Program.
This person is not in any offices
Rénibus Therapeutics
Rénibus Therapeutics is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention, treatment, and diagnostic testing of kidney disease.